Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapeutic experience with 5-chloro-8-hydroxyquinoline].

R Gärtner, U Kaben

    Dermatologische Monatschrift
    |September 1, 1977
    PubMed
    Summary

    This study evaluated a new antimycoticum containing 5-chlorine-8-hydroxyquinoline. Local treatment of surface dermatomycoses in 142 patients showed a 68% clinical and mycological healing rate.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Teprotumumab for thyroid-associated ophthalmopathy : OPTIC].

    Der Internist·2020
    Same author

    [Thyroid emergencies : Thyroid storm and myxedema coma].

    Der Internist·2017
    Same author

    [Not Available].

    MMW Fortschritte der Medizin·2016
    Same author

    Developing Demonstration Test Catchments as a platform for transdisciplinary land management research in England and Wales.

    Environmental science. Processes & impacts·2014
    Same author

    Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy.

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2013
    Same author

    [Thyroid hormone treatment].

    Deutsche medizinische Wochenschrift (1946)·2013

    Area of Science:

    • Dermatology
    • Mycology
    • Pharmacology

    Context:

    • Surface dermatomycoses are common fungal skin infections.
    • Antimycotic agents are crucial for treating these conditions.
    • Evaluating novel therapeutic agents is essential for improving patient outcomes.

    Purpose:

    • To assess the efficacy and safety of a novel antimycoticum containing 5-chlorine-8-hydroxyquinoline.
    • To determine the clinical and mycological healing rates in patients with superficial dermatomycoses.
    • To evaluate the impact of epicutaneous tests and UV exposition on treatment outcomes.

    Summary:

    • A clinical trial involving 142 patients with surface dermatomycoses was conducted.
    • Patients received local treatment with the 5-chlorine-8-hydroxyquinoline-based antimycoticum for 5-6 weeks.
    • Overall, 68% of patients achieved clinical and mycological healing, with the best results observed in Trichophytia inguinalis.

    Impact:

    • The study demonstrates the potential of 5-chlorine-8-hydroxyquinoline as an effective topical treatment for superficial dermatomycoses.
    • Findings support the use of this antimycoticum, particularly for conditions like Trichophytia inguinalis.
    • Further research may explore its application in broader dermatological fungal infections.

    Related Experiment Videos